Heyman Richard A.

EDGAR CIK 0001584759

Enliven Therapeutics, Inc. - ELVN

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director
Direct Buys
0
$0
0 Shares
Direct Sells
6
($209,608)
-7,970 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
1
($22,592)
-753 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
10/18/2024
10b5-1
10/22/2024
Sell
-817 @ $30.00
 ($24,512) 123,673 (-0.66%) Direct
10/18/2024
10b5-1
10/22/2024
Sell
-753 @ $30.00
 ($22,592) 27,165 (-2.70%) Indirect - See footnote
10/15/2024
10b5-1
10/17/2024
Sell
-1,270 @ $27.67
 ($35,143) 124,490 (-1.01%) Direct
10/04/2024
10b5-1
10/08/2024
Sell
-2,825 @ $27.51
 ($77,704) 125,760 (-2.20%) Direct
10/01/2024
10b5-1
10/03/2024
Sell
-518 @ $27.54
 ($14,264) 128,585 (-0.40%) Direct
09/16/2024
10b5-1
09/18/2024
Sell
-1,270 @ $22.41
 ($28,458) 129,103 (-0.97%) Direct
08/15/2024
10b5-1
08/19/2024
Sell
-1,270 @ $23.25
 ($29,526) 130,373 (-0.96%) Direct